膀胱癌檢測套件的全球市場:現狀分析與預測(2022年～2028年)

全球膀胱癌檢測套件的市場規模，在預測期間內預計以約11％的年複合成長率成長。膀胱癌的發生率增加，癌症與其治療方法相關認識度的提高，醫療費的支出增加，抽煙、香煙消費的擴大，促進市場成長。

本報告提供全球膀胱癌檢測套件市場的相關調查，市場洞察，市場趨勢，競爭模式，企業概要等全面性資訊。

目錄

第1章 市場簡介

• 市場定義
• 主要目的
• 相關利益者
• 限制

第2章 調查方法或假設

• 膀胱癌檢測套件市場調查流程
• 膀胱癌檢測套件市場調查手法
• 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對膀胱癌檢測套件市場的影響

第6章 膀胱癌檢測套件的市場收益(10億美元)(2022年～2028年)

第7章 市場洞察:各技術

• 螢光原位雜合反應(FISH)
• 酵素免疫分析法(ELISA)
• 其他

第8章 市場洞察:各類型

• 血液樣品檢驗
• 尿樣品檢驗
• 細胞樣品檢驗

第9章 市場洞察:各終端用戶

• 醫院和診所
• 診斷中心
• 居家醫療
• 研究中心
• 其他

第10章 市場洞察:各地區

• 北美
  • 美國
  • 加拿大
  • 其他北美
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 全球其他地區

第11章 膀胱癌檢測套件的市場動態

• 推動市場要素
• 市場課題
• 影響分析

第12章 膀胱癌檢測套件的市場機會

第13章 膀胱癌檢測套件的市場趨勢

第14章 需求面和供給方面的分析

• 需求面分析
• 供給面

第15章 價值鏈分析

第16章 競爭模式

• 競爭情形
  • 波特的五力分析

第17章 企業概要

• Cepheid
• BIOSYNEX SA
• Abbott Laboratories
• EXACT Sciences Corporation
• Abingdon Health PLC
• Xiamen Biotime Biotechnology Co., Ltd.
• IDL Biotech AB
• Alfa Scientific Designs
• Biomerica Inc
• Hologic Inc.

第18章 免責聲明

Global Bladder Cancer Detection Kit Market is expected to grow at a significant rate of around 11% during the forecast period. This is mainly due to the increasing incidence of bladder cancer, increase in awareness about cancer and its available therapies, growing healthcare expenditure, and expanding smoking and tobacco consumption are anticipated to accelerate the market of the bladder cancer detection kit market. According to Globocan, the global burden of bladder cancer is significantly high, representing 3.0% of all new cancer diagnoses, 2.1% of all cancer deaths in 2020, and the 11thmost frequently diagnosed cancer worldwide. Hence, the government authorities are keenly observing the development of products related to bladder cancer detection kits. Furthermore, the growing focus of major players on different growth strategies such as research and development activities, and product approvals are further expected to increase the market. Thus, the growing focus and investment of key stakeholders in the research and development of technologically advanced bladder cancer detection kits is further expected to grow the market.

Cepheid, BIOSYNEX SA, Abbott Laboratories, EXACT Sciences Corporation, Abingdon Health PLC, Xiamen Biotime Biotechnology Co., Ltd., IDL Biotech AB, Alfa Scientific Designs, Biomerica Inc, Hologic Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

"Amongst technology, fluorescence in situ hybridization (FISH) category to witness significant CAGR during the forecast period"

Based on type, the market is segmented into fluorescence in situ hybridization (FISH), enzyme-linked immunosorbent assay (ELISA), and others. The fluorescence in situ hybridization (FISH) category witnessed a significant CAGR during the forecast period. This segment is expected to take the lead since it is a unique urine examination technology that uses fluorescent direct-tagged DNA probes to detect genetic abnormalities in urothelial cells detected in the urine.

"Amongst end user, the hospitals & clinics to hold a significant share in the market in 2020"

On the basis of end-user, the market is categorized into hospitals & clinics, diagnostic centre, home care, research centers, and others. Among these, the hospitals & clinics to hold a significant share in the market in 2020. The bladder cancer detection kit market in hospital infrastructure is being driven globally by innovations. Moreover, The investor building cancer detection and treatment hospitals are leveraging the bladder cancer market.

"North America to hold a significant share in the market"

In 2020, North America held a significant share of the global bladder cancer detection kit market. This is mainly attributed to the rising prevalence of bladder cancer across the region is driving the North American bladder cancer detection kit market. According to the American Cancer Society, about 83,730 new cases of bladder cancer and approximately 17,200 deaths from bladder cancer occurred in the US in 2020. Moreover, The development of the bladder cancer detection kit market in these regions is anticipated to be supported further by increased R&D investments, bettering healthcare infrastructure, and more government initiatives. As the prevalence and mortality rate is rising worldwide, the demand for bladder cancer diagnosis is increasing. This further increases the investment in R&D of non-invasive bladder cancer detection products, hence driving the bladder cancer detection kit market growth.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global bladder cancer detection kit market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Bladder Cancer Detection Kit Market
• 2.2. Research Methodology of the Bladder Cancer Detection Kit Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BLADDER CANCER DETECTION KIT MARKET

6 BLADDER CANCER DETECTION KIT MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY TECHNOLOGY

• 7.1. Fluorescence In Situ Hybridization (FISH)
• 7.2. Enzyme-Linked Immunosorbent Assay (ELISA)
• 7.3. Others

8 MARKET INSIGHTS BY TYPE

• 8.1. Blood Sample Test
• 8.2. Urine Sample Test
• 8.3. Cell Sample Test

9 MARKET INSIGHTS BY END USER

• 9.1. Hospitals & Clinics
• 9.2. Diagnostic Centre
• 9.3. Home Care
• 9.4. Research centers
• 9.5. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. The U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. The U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 BLADDER CANCER DETECTION KIT MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 BLADDER CANCER DETECTION KIT MARKET OPPORTUNITIES

13 BLADDER CANCER DETECTION KIT MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

• 16.1. Competitive Landscape
  • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

• 17.1. Cepheid
• 17.2. BIOSYNEX SA
• 17.3. Abbott Laboratories
• 17.4. EXACT Sciences Corporation
• 17.5. Abingdon Health PLC
• 17.6. Xiamen Biotime Biotechnology Co., Ltd.
• 17.7. IDL Biotech AB
• 17.8. Alfa Scientific Designs
• 17.9. Biomerica Inc
• 17.10. Hologic Inc.

18 DISCLAIMER